Rights and permissions
About this article
Cite this article
Docetaxel + carboplatin has the edge for advanced NSCLC. Inpharma Wkly. 1555, 13 (2006). https://doi.org/10.2165/00128413-200615550-00035
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615550-00035